NCT03565055

Brief Summary

This research project aims at early detection, early intervention, and recovery of individuals with psychosis and prevention of their family members who are at high risk of having developmental problems and developing psychosis episode in later stages of their life. It consists of two major parts with the following study designs \& aims: Part I : Developing a comprehensive and integrative psychosocial and community skills training programme (IPCST) and conducing a pilot randomised controlled trial to compare the study outcomes between the two settings in Hong Kong and Beijing.

  1. 1.To develop IPCST as an innovative intervention model targeting individuals with first or recent onset of psychosis to reduce their stay in mental hospital and bridges them to independent living in the community with optimal social and professional support;
  2. 2.To evaluate IPCST in terms of the clinical, vocational, and psychosocial outcomes of participants using a randomized controlled trial design and compare these outcomes between Hong Kong and Beijing;
  3. 3.To examine the cost-effectiveness of IPCST in the two cities; and
  4. 4.To train professionals and research personnel in Hong Kong and mainland for implementation
  5. 5.To identify the potential developmental problems or sufferings of theses younger family members living with patients with mental illness;
  6. 6.To provide baseline assessment of their psychosocial stress, mental health, and quality of life;
  7. 7.To identify interventions that may prevent them from developing psychosis and other developmental problems and improve their mental health.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2018

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 28, 2017

Completed
10 months until next milestone

First Posted

Study publicly available on registry

June 21, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

August 1, 2018

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

June 21, 2018

Status Verified

June 1, 2018

Enrollment Period

1.3 years

First QC Date

August 28, 2017

Last Update Submit

June 20, 2018

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change of Positive and Negative Syndrome Scale (PANSS) score

    The Positive and Negative Syndrome Scale (PANSS) is a medical scale used for measuring symptom severity of patients with schizophrenia. Participants will be assessed by medical specialist who will complete their PANSS at baseline, immediately following the completion of the 3-month program, and at 6- \& 12- months after completion of the program. The Change of PANSS score over the above time course is the study's primary outcome measure.

    Baseline, Completion of the 3-month program, and follow up at 6-, 12- month

  • Change of The Personal and Social Performance Scale (PSP) score

    The Personal and Social Performance scale (PSP) is widely used to assess social functioning in patients with schizophrenia. Participants will be assessed by medical specialist who will complete their PSP score at baseline, immediately following the completion of the 3-month program, and at 6- \& 12- months after completion of the program. The Change of PSP score over the above time course is the study's primary outcome measure.

    Baseline, Completion of the 3-month program, and follow up at 6-, 12- month

Secondary Outcomes (5)

  • Change of Employment Outcome Checklist (EOC) score

    Baseline, Completion of the 3-month program, and follow up at 6-, 12- month

  • Change of The Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4) score

    Baseline, Completion of the 3-month program, and follow up at 6-, 12- month

  • Change of the Vocational Social Skills Assessment Scale (VSSS) score

    Baseline, Completion of the 3-month program, and follow up at 6-, 12- month

  • Change of Re-hospitalization rate

    Baseline, Completion of the 3-month program, and follow up at 6-, 12- month

  • Change of outpatient follow-up rate

    Baseline, Completion of the 3-month program, and follow up at 6-, 12- month

Study Arms (2)

IPCST

EXPERIMENTAL

Intervention = Patients that participate in IPCST programme

Behavioral: IPCST

E.A.S.Y

ACTIVE COMPARATOR

Treatment as usual = Patients of E.A.S.Y Programme in HK Kwai Chung Hospital

Behavioral: E.A.S.Y

Interventions

IPCSTBEHAVIORAL

Integrative Psychosocial \& Community Skills Training (IPCST) programme The IPCST programme includes: 1. psychoeducation, internalized stigma reduction, \& strength and coping enhancement 2. motivational interviewing skills 3. Neurocognitive and social cognitive training (Au, Tsang, So, Bell, Cheung, et al., 2015) 4. augmented supported employment with social skills training (Tsang, Fung, Li, Leung \& Cheung, 2010) and 5. family and patient involvement in care

IPCST
E.A.S.YBEHAVIORAL

The E.A.S.Y. (Early Assessment Service for Young People with Early Psychosis) Programme is a service programme for people suffering from early psychosis. The E.A.S.Y programme includes: 1. Extensive public education 2. Early referral and assessment 3. Ongoing treatment services

E.A.S.Y

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Hong Kong/ China residents
  • Age between 18-55 years;
  • Primary diagnosis of psychosis (not more than 12 months of clinical diagnosis) by psychiatrist and confirmed with the SCID-I for DSM-IV TR Axis I Disorders (Biometrics Research, 2002);
  • Primary six or above education;
  • Mentally competent to follow the instructions and training and give informed written consent, as suggested by the attending psychiatrist;
  • Able to communicate in Chinese;
  • Intend to seek employment.

You may not qualify if:

  • Co-morbidity of learning disability, neurological disorder (e.g., epilepsy) and organic brain disease, or clinically significant medical diseases;
  • Recently participated or are participating in other structured psychosocial intervention, and/or
  • Visual, language or communication difficulty.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Psychotic Disorders

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Central Study Contacts

Hector Wing-Hong TSANG, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Head

Study Record Dates

First Submitted

August 28, 2017

First Posted

June 21, 2018

Study Start

August 1, 2018

Primary Completion

December 1, 2019

Study Completion

December 1, 2019

Last Updated

June 21, 2018

Record last verified: 2018-06